GSK
BLENREP
Manufacturer:
GSK
Name:
BLENREP
HCPCS Code Descriptor:
Injection, belantamab mafodotin-blmf, 0.5 mg
Category:
J Code
HCPCS:
J9037
NDC(s):
00173-0896-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
BLENREP is an Oncology drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J9037 is aligned to the drug BLENREP.